C
Centro Mineiro de Pesquisa | Juiz de Fora, Brazil
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Daxdilimab
Povetacicept
SAR441566
HZN-7734
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
The primary efficacy objective:To evaluate the effect of daxdilimab compared with placebo in reducing disease activity at Week 24.The secondary effic...
Active, not recruiting
Idiopathic Inflammatory Myositis
Drug: Daxdilimab
Drug: Placebo
This is a parallel group, Phase 2, randomized, double-blind, placebo controlled, 5-arm, international, multicenter, 12-week proof of concept, dose fi...
Active, not recruiting
Rheumatoid Arthritis
Drug: SAR441566
Drug: Placebo
The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...
Enrolling
Immunoglobulin A Nephropathy
Drug: Placebo (matched to Povetacicept)
Drug: Povetacicept
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems